Pfizer to close Irish Plant
This article was originally published in Scrip
Executive Summary
Pfizer is closing its Little Island manufacturing plant in Cork, part of the latest phase of its restructuring plans in Ireland. The site, which currently employs 136 people, will shut before the end of next year. According to the company, the decision is based on a "global effort to align manufacturing capacity", related to the expiration of key patents and the need to find more efficiencies in production. Work from the site will move to one of Pfizer's other Irish plants in Ringaskiddy. Vice-president Paul Duffy, said the country remains a key strategic location for the New York-based company, "with extensive operations in Cork, Kildare and Dublin [ongoing]". Currently, Pfizer employs more than 3,200 people across six sites in the country.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.